These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3470668)

  • 41. Tracing the footsteps of glomerular insulin signaling in diabetic kidney disease.
    Chang GY; Park AS; Susztak K
    Kidney Int; 2011 Apr; 79(8):802-4. PubMed ID: 21451535
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dietary protein and the diabetic kidney.
    Wiseman MJ; Dodds R; Bending JJ; Viberti GC
    Diabet Med; 1987; 4(2):144-6. PubMed ID: 2952431
    [No Abstract]   [Full Text] [Related]  

  • 43. [Orthostatic albuminuria].
    Diekmann L
    Anasthesiol Intensivmed Prax; 1977 Feb; 13(1):34. PubMed ID: 879482
    [No Abstract]   [Full Text] [Related]  

  • 44. Early functional and morphologic vascular renal consequences of the diabetic state.
    Viberti GC; Haycock GB; Pickup JC; Jarrett RJ; Keen H
    Diabetologia; 1980; 18(2):173-7. PubMed ID: 6988278
    [No Abstract]   [Full Text] [Related]  

  • 45. [Hyponatremia. Physiopathological significance and therapeutic implications].
    Febres Roman PR; Tzamaloukas AH
    Rev Clin Esp; 1979 May; 153(3):173-5. PubMed ID: 482687
    [No Abstract]   [Full Text] [Related]  

  • 46. Back to the Future: Glomerular Hyperfiltration and the Diabetic Kidney.
    Tuttle KR
    Diabetes; 2017 Jan; 66(1):14-16. PubMed ID: 27999101
    [No Abstract]   [Full Text] [Related]  

  • 47. Impairment of ECM production.
    Horikoshi S; Kanamaru Y; Funabiki K; Tomino Y
    Contrib Nephrol; 2001; (134):63-8. PubMed ID: 11665289
    [No Abstract]   [Full Text] [Related]  

  • 48. Letter to the Editor: "Can early plasma elimination rate be used to quantify renal clearance of macromolecules?".
    Öberg CM; Rippe B
    Am J Physiol Renal Physiol; 2015 Jan; 308(2):F164-5. PubMed ID: 25560050
    [No Abstract]   [Full Text] [Related]  

  • 49. Albumin: innocent bystander or culprit?
    Peired AJ; Bitzer M
    Am J Physiol Renal Physiol; 2016 Aug; 311(2):F409-10. PubMed ID: 27306981
    [No Abstract]   [Full Text] [Related]  

  • 50. NLR and microalbuminuria: Are these markers significantly associated?
    Umeres-Francia GE; Rojas-Fernández MV; Benites-Zapata VA
    Rom J Intern Med; 2018 Jun; 56(2):127. PubMed ID: 29168977
    [No Abstract]   [Full Text] [Related]  

  • 51. Microalbuminuria and normal protein filtration in the kidney.
    Shand B
    N Z Med J; 1987 Feb; 100(818):108-10. PubMed ID: 3470668
    [No Abstract]   [Full Text] [Related]  

  • 52. [Pathogenicity of glomerular hyperfiltration, a question of glomerular tolerance?].
    Wüstenberg PW; Dabels J
    Z Gesamte Inn Med; 1990 Apr; 45(8):210-4. PubMed ID: 2198716
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Microalbuminuria: its pathophysiology, diagnostic significance and the methods of its study].
    Titov VN; Tarasov AV
    Ter Arkh; 1988; 60(6):134-40. PubMed ID: 3061047
    [No Abstract]   [Full Text] [Related]  

  • 54. [Predicting diabetic nephropathy].
    Mogensen CE; Christensen CK
    Journ Annu Diabetol Hotel Dieu; 1984; ():333-49. PubMed ID: 6399537
    [No Abstract]   [Full Text] [Related]  

  • 55. Controversies on the prevention of diabetic nephropathy.
    Chiarelli F; Verrotti A; Basciani F; di Ricco L; Sabatino G; Morgese G
    J Pediatr Endocrinol Metab; 1998 Apr; 11 Suppl 2():365-9. PubMed ID: 9642666
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.